491 related articles for article (PubMed ID: 34232978)
1. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
[TBL] [Abstract][Full Text] [Related]
2. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
Front Immunol; 2020; 11():1022. PubMed ID: 32574260
[TBL] [Abstract][Full Text] [Related]
3. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine therapy during the COVID-19 pandemic.
Rudnicka L; Glowacka P; Goldust M; Sikora M; Sar-Pomian M; Rakowska A; Samochocki Z; Olszewska M
J Am Acad Dermatol; 2020 Aug; 83(2):e151-e152. PubMed ID: 32376422
[No Abstract] [Full Text] [Related]
5. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
[TBL] [Abstract][Full Text] [Related]
6. [Strategies for vaccine development of COVID-19].
Yang L; Tian D; Liu W
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
[TBL] [Abstract][Full Text] [Related]
7. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
Zhang YY; Li BR; Ning BT
Front Immunol; 2020; 11():2033. PubMed ID: 32922406
[TBL] [Abstract][Full Text] [Related]
8. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
Sariol A; Perlman S
Immunity; 2020 Aug; 53(2):248-263. PubMed ID: 32717182
[TBL] [Abstract][Full Text] [Related]
9. Human Coronaviruses: Counteracting the Damage by Storm.
Schoeman D; Fielding BC
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452323
[TBL] [Abstract][Full Text] [Related]
10. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
Wang Y; Grunewald M; Perlman S
Methods Mol Biol; 2020; 2203():1-29. PubMed ID: 32833200
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.
Ansariniya H; Seifati SM; Zaker E; Zare F
Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683
[TBL] [Abstract][Full Text] [Related]
12. Introduction - Emerging Pathogens and the COVID-19 Pandemic.
McFee RB
Dis Mon; 2020 Sep; 66(9):101065. PubMed ID: 32758362
[No Abstract] [Full Text] [Related]
13. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
Yao Z; Zheng Z; Wu K; Junhua Z
Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
Ye ZW; Jin DY
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.
Singh A; Singh RS; Sarma P; Batra G; Joshi R; Kaur H; Sharma AR; Prakash A; Medhi B
Virol Sin; 2020 Jun; 35(3):290-304. PubMed ID: 32607866
[TBL] [Abstract][Full Text] [Related]
16. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
17. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
Quan C; Li C; Ma H; Li Y; Zhang H
Clin Microbiol Rev; 2020 Oct; 34(1):. PubMed ID: 33055229
[TBL] [Abstract][Full Text] [Related]
18. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
Wu Z; Harrich D; Li Z; Hu D; Li D
Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
[TBL] [Abstract][Full Text] [Related]
19. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
İnandıklıoğlu N; Akkoc T
Adv Exp Med Biol; 2020; 1288():5-12. PubMed ID: 32514817
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus vaccine-associated lung immunopathology-what is the significance?
Bottazzi ME; Strych U; Hotez PJ; Corry DB
Microbes Infect; 2020 Oct; 22(9):403-404. PubMed ID: 32599077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
